Use of amino-terminal pro-B type natriuretic peptide as the parameter for long term monitoring of water overload in patient with chronic kidney diseases

Prnjavorac, Besim; Abduzaimović, Kadrija; Jukić, Jasna; Sejdinović, Rifat; Mujarić, Ekrema; Irejiz, Nedžada; Hadžović-Džuvo, Almira; Jadrić, Radivoj; Čaušević, Adlija; Semiz, Sabina; Bego, Tamer; Malenica, Maja
February 2011
Medicinski Glasnik;Feb2011, Vol. 8 Issue 1, p116
Academic Journal
No abstract available.


Related Articles

  • Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Mallamaci, Francesca; Zoccali, Carmine; Tripepi, Giovanni; Benedetto, Francesco A.; Parlongo, Saverio; Cataliotti, Alessandro; Cutrupi, Sebastiano; Giacone, Giuseppe; Bellanuova, Ignazio; Stancanelli, Benedetta; Malatino, Lorenzo S. // Kidney International;Apr2001, Vol. 59 Issue 4, p1559 

    Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Background. In the general population, the plasma concentrations of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are useful to predict left ventricular hypertrophy (LVH) and LV systolic...

  • Salt-losing nephropathy associated with inappropriate secretion of atrial natriuretic peptide � a new clinical syndrome. Rodr�guez-Soriano, Juan; Vallo, Alfredo // Pediatric Nephrology;1997, Vol. 11 Issue 5, p565 

    A state of normokalemic renal sodium wasting associated with an apparently inappropriate secretion of atrial natriuretic peptide (ANP) has not been previously recognized. We here report an 11-year-old boy who presented with a chronic "salt-losing" nephropathy manifested by normonatremic or...

  • N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Franz, Martina; Woloszczuk, Wolfgang; Hörl, Walter H. // Kidney International;Jul2000, Vol. 58 Issue 1, p374 

    N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Background. Fragments derived from the prohormone of α-human atrial natriuretic peptide (α-ANP) in patients with cardiac failure are more closely related to the disease state than...

  • Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients. Astrup, Anne Sofie; Kim, Won Yong; Tarnow, Lise; Botnar, René M.; Simonsen, Cheryl; Brix, Lau; Pietraszek, Lotte; Hansen, Peter Riis; Manning, Warren J.; Parving, Hans-Henrik // Diabetes Care;May2008, Vol. 31 Issue 5, p968 

    OBJECTIVES -- To measure left ventricular mass (LVM), left ventricular volumes, and left ventricular function (LVF) in a cohort of type 1 diabetic patients and to correlate measures of imaging to NH2-terminal pro-brain natriuretic peptide (NT-proBNP). RESEARCH DESIGN AND METHODS -- In a...

  • Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? Struthers, Allan D. // BMJ: British Medical Journal (International Edition);6/18/94, Vol. 308 Issue 6944, p1615 

    Identifies amino acid structure of atrial natriuretic peptide. Examination on therapeutic potential of atrial natriuretic peptide; Discovery on brain natriuretic peptide in the porcine brain; Source of peptide.

  • B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention. Jing Zhang; Xianghua Fu; Xinwei Jia; Xinna Fan; Xinshun Gu; Shiqiang Li; Weili Wu; Weize Fan; Jianling Su; Guozhen Hao; Yunfa Jiang; Ling Xue // Acta Radiologica;Jul2010, Vol. 51 Issue 6, p641 

    Background: Contrast-induced nephropathy (CIN) is one of the leading causes of hospital-acquired renal failure and increase in the mortality and length of hospital stay after percutaneous coronary intervention (PCI). Purpose: To evaluate the protective effect of B-type natriuretic peptide (BNP)...

  • Natriuretic Peptides.  // Encyclopedic Reference of Molecular Pharmacology;2004, p625 

    An encyclopedia entry for "natriuretic peptides" is presented. They refer to a family of peptide hormones that contain a 17-amino acid long ring closed by a disulfide bond between cysteine residues. Atrial natriuretic peptide is expressed in the heart's atria, while B-type natriuretic peptide is...

  • 875. Development of Human Skin Gene Therapy for Systemic In Vivo Delivery of Atrial Natriuretic Peptide (ANP) To Treat Hypertension. Therrien, Jean-Philippe; Tock, Christine L.; Vogel, Jonathan C. // Molecular Therapy;Jun2006, Vol. 13, pS337 

    Skin is a very attractive organ for targeted gene therapy to systemically deliver therapeutic proteins to treat cancers, skin diseases or systemic diseases. Since skin is a renewable tissue, achieving long-term stable expression of a therapeutic gene requires targeting keratinocytes stem cells...

  • Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Tsutamoto, Takayoshi; Kawahara, Chiho; Yamaji, Masayuki; Nishiyama, Keizo; Fujii, Masanori; Yamamoto, Takashi; Horie, Minoru // European Journal of Heart Failure;Jul2009, Vol. 11 Issue 7, p653 

    Aims: Both serum cardiac troponin T (cTnT) and renal function are prognostic predictors in patients with chronic heart failure (CHF). We aimed to evaluate the relationship between renal function and serum cTnT.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics